BCL2 and cutaneous melanoma: Our study revealed that DIOS significantly suppressed the proliferation and migration of cutaneous melanoma cells, reduced the levels of Bcl-2, and increased the protein expressions of Cleaved caspase-9, Cleaved caspase-3, and Cleaved PARP.